Lipid exchange of apolipoprotein A-I amyloidogenic variants in reconstituted high-density lipoprotein with artificial membranes

被引:1
|
作者
Correa, Yubexi [1 ,2 ]
Ravel, Mathilde [1 ,2 ]
Imbert, Marie [1 ,2 ]
Waldie, Sarah [1 ,2 ]
Clifton, Luke [3 ]
Terry, Ann [4 ]
Roosen-Runge, Felix [1 ,2 ]
Lagerstedt, Jens O. [5 ,6 ]
Moir, Michael [7 ]
Darwish, Tamim [7 ,8 ]
Cardenas, Marite [1 ,2 ,9 ,10 ,11 ]
Del Giudice, Rita [1 ,2 ,12 ]
机构
[1] Malmo Univ, Biofilm Res Ctr Biointerfaces, Malmo, Sweden
[2] Malmo Univ, Fac Hlth & Soc, Dept Biomed Sci, Malmo, Sweden
[3] Harwell Sci & Innovat Campus, Sci & Technol Facil Council, Rutherford Appleton Lab, ISIS Pulsed Neutron & Muon Source, Didcot, England
[4] Lund Univ, MAX Lab 4, CoSAXS Beamline, Lund, Sweden
[5] Lund Univ, Diabet Ctr, Dept Clin Sci Malmo, Islet Cell Exocytosis, Malmo, Sweden
[6] Novo Nordisk, Rare Endocrine Disorders, Res & Early Dev, Copenhagen, Denmark
[7] Australian Nucl Sci & Technol Org ANSTO, Natl Deuterat Facil, Lucas Heights, NSW, Australia
[8] Univ Canberra, Fac Sci & Technol, Canberra, ACT, Australia
[9] Basque Fdn Sci, Ikerbasque, Bilbao, Spain
[10] Univ Basque Country, Biofis Inst, Leioa, Spain
[11] Malmo Univ, Biofilm Res Ctr Biointerfaces, S-20506 Malmo, Sweden
[12] Malmo Univ, Fac Hlth & Soc, Dept Biomed Sci, S-20506 Malmo, Sweden
关键词
amyloidogenic variants; apolipoprotein A-I; high-density lipoprotein; reconstituted HDL; X-RAY-SCATTERING; APOA-I; CHOLESTEROL; BILAYERS; ACID; CONFORMATIONS; MODEL; ORGANIZATION; BIOGENESIS; THERAPIES;
D O I
10.1002/pro.4987
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-density lipoproteins (HDLs) are responsible for removing cholesterol from arterial walls, through a process known as reverse cholesterol transport. The main protein in HDL, apolipoprotein A-I (ApoA-I), is essential to this process, and changes in its sequence significantly alter HDL structure and functions. ApoA-I amyloidogenic variants, associated with a particular hereditary degenerative disease, are particularly effective at facilitating cholesterol removal, thus protecting carriers from cardiovascular disease. Thus, it is conceivable that reconstituted HDL (rHDL) formulations containing ApoA-I proteins with functional/structural features similar to those of amyloidogenic variants hold potential as a promising therapeutic approach. Here we explored the effect of protein cargo and lipid composition on the function of rHDL containing one of the ApoA-I amyloidogenic variants G26R or L174S by Fourier transformed infrared spectroscopy and neutron reflectometry. Moreover, small-angle x-ray scattering uncovered the structural and functional differences between rHDL particles, which could help to comprehend higher cholesterol efflux activity and apparent lower phospholipid (PL) affinity. Our findings indicate distinct trends in lipid exchange (removal vs. deposition) capacities of various rHDL particles, with the rHDL containing the ApoA-I amyloidogenic variants showing a markedly lower ability to remove lipids from artificial membranes compared to the rHDL containing the native protein. This effect strongly depends on the level of PL unsaturation and on the particles' ultrastructure. The study highlights the importance of the protein cargo, along with lipid composition, in shaping rHDL structure, contributing to our understanding of lipid-protein interactions and their behavior.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles
    Sigalov, AB
    Stern, LJ
    CHEMISTRY AND PHYSICS OF LIPIDS, 2001, 113 (1-2) : 133 - 146
  • [32] Thermal Stability of Apolipoprotein A-I in High-Density Lipoproteins by Molecular Dynamics
    Jones, Martin K.
    Catte, Andrea
    Patterson, James C.
    Gu, Feifei
    Chen, Jianguo
    Li, Ling
    Segrest, Jere P.
    BIOPHYSICAL JOURNAL, 2009, 96 (02) : 354 - 371
  • [33] Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes
    Mizuguchi, Chiharu
    Ogata, Fuka
    Mikawa, Shiho
    Tsuji, Kohei
    Baba, Teruhiko
    Shigenaga, Akira
    Shimanouchi, Toshinori
    Okuhira, Keiichiro
    Otaka, Akira
    Saito, Hiroyuki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (34) : 20947 - 20959
  • [34] HUMAN APOLIPOPROTEIN A-I FORMS SMALL HIGH-DENSITY-LIPOPROTEIN PARTICLES IN RATS INVIVO
    HA, YC
    TRIFUNOVIC, Z
    HOWLETT, GJ
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1125 (02) : 223 - 229
  • [35] Conservation of Apolipoprotein A-I's Central Domain Structural Elements upon Lipid Association on Different High-Density Lipoprotein Subclasses
    Oda, Michael N.
    Budamagunta, Madhu S.
    Geier, Ethan G.
    Chandradas, Sajiv H.
    Shao, Baohai
    Heinecke, Jay W.
    Voss, John C.
    Cavigiolio, Giorgio
    BIOCHEMISTRY, 2013, 52 (39) : 6766 - 6778
  • [36] High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
    Gordon, Elizabeth M.
    Figueroa, Debbie M.
    Barochia, Amisha V.
    Yao, Xianglan
    Levine, Stewart J.
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [37] Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups
    Davidson, MH
    Ose, L
    Frohlich, J
    Scott, RS
    Dujovne, CA
    Escobar, ID
    Bertolami, MC
    Cihon, F
    MacCubbin, DL
    Mercuri, M
    CLINICAL CARDIOLOGY, 2003, 26 (11) : 509 - 514
  • [38] Role of free apolipoprotein A-I in cholesterol efflux - Formation of pre-alpha-migrating high-density lipoprotein particles
    Asztalos, B
    Zhang, WW
    Roheim, PS
    Wong, L
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) : 1630 - 1636
  • [39] Pharmacological Intervention Using Reconstituted High-Density Lipoprotein Changes in the Lipid Profile in Spontaneously Hypersensitive Rats
    Imaizumi, Satoshi
    Kiya, Yoshihiro
    Miura, Shin-Ichiro
    Zhang, Bo
    Matsuo, Yoshino
    Uehara, Yoshinari
    Rye, Kerry-Anne
    Saku, Keijiro
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2010, 32 (03) : 202 - 208
  • [40] Structure/Function Relationships of Apolipoprotein A-I Mimetic Peptides Implications for Antiatherogenic Activities of High-Density Lipoprotein
    D'Souza, Wilissa
    Stonik, John A.
    Murphy, Andrew
    Demosky, Steven J.
    Sethi, Amar A.
    Moore, Xiao L.
    Chin-Dusting, Jaye
    Remaley, Alan T.
    Sviridov, Dmitri
    CIRCULATION RESEARCH, 2010, 107 (02) : 217 - U110